Viewing Study NCT05824494


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-05-16 @ 6:30 PM
Study NCT ID: NCT05824494
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-05-06
First Post: 2023-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
Sponsor:
Organization: